Welcome to LookChem.com Sign In|Join Free

CAS

  • or

112100-39-7

Post Buying Request

112100-39-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • BUTANOIC ACID, 3-HYDROXY-4-IODO-, ETHYL ESTER, (S)

    Cas No: 112100-39-7

  • No Data

  • No Data

  • No Data

  • SYNTHON
  • Contact Supplier

112100-39-7 Usage

General Description

Butanoic acid, 3-hydroxy-4-iodo-, ethyl ester, (S) is a chemical compound that belongs to the class of esters. It is a colorless liquid with a fruity odor and is used as a flavoring agent in the food and beverage industry. BUTANOIC ACID, 3-HYDROXY-4-IODO-, ETHYL ESTER, (S) is also used in the production of perfumes and as a fragrance in personal care products. It is often added to products such as soaps, lotions, and shampoos to impart a pleasant scent. Additionally, it has potential applications in the pharmaceutical industry as a building block for the synthesis of various pharmaceutical compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 112100-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,1,0 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 112100-39:
(8*1)+(7*1)+(6*2)+(5*1)+(4*0)+(3*0)+(2*3)+(1*9)=47
47 % 10 = 7
So 112100-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H11IO3/c1-2-10-6(9)3-5(8)4-7/h5,8H,2-4H2,1H3/t5-/m1/s1

112100-39-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name BUTANOIC ACID, 3-HYDROXY-4-IODO-, ETHYL ESTER, (S)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112100-39-7 SDS

112100-39-7Relevant articles and documents

Straightforward and efficient synthesis of (4R,6S)-4-(tert-butyldimethyl- siloxy)-6-(hydroxymethyl)tetrahydropyran-2-one

?asar, Zdenko

, p. 2036 - 2040 (2008)

A novel synthetic approach to (4R,6S)-4-(tert-butyldimethylsiloxy)-6- (hydroxymethyl)tetrahydropyran-2-one, a key precursor of statin side chain, is described. A prime feature of the presented strategy is the transformation of (4R,6S)-4-(tert-butyldimethylsiloxy)-6-(iodomethyl)tetrahydropyran-2-one to an acetate ester derivative and subsequent cleavage of an acetate protection by applying homogeneous tin catalysis. Iodolactone used in the study is accessible by a new route in five steps from (S)-ethyl 4-chloro-3-hydroxybutanoate. This method overcomes many of the drawbacks associated with previously reported approaches. It gives the title compound in 21% over seven steps, which is the highest attained overall yield yet. The disclosed approach was realized in convenient and economical manner suitable for industrial use.

SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES

-

Page/Page column 115, (2021/06/26)

Provided herein are pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.

Cation-π interactions contribute to substrate recognition in γ-butyrobetaine hydroxylase catalysis

Kamps, Jos J. A. G.,Khan, Amjad,Choi, Hwanho,Lesniak, Robert K.,Brem, Jürgen,Rydzik, Anna M.,McDonough, Michael A.,Schofield, Christopher J.,Claridge, Timothy D. W.,Mecinovic, Jasmin

supporting information, p. 1270 - 1276 (2016/01/25)

γ-Butyrobetaine hydroxylase (BBOX) is a non-heme FeII- and 2-oxoglutarate-dependent oxygenase that catalyzes the stereoselective hydroxylation of an unactivated C-H bond of γ-butyrobetaine (γBB) in the final step of carnitine biosynthesis. BBOX contains an aromatic cage for the recognition of the positively charged trimethylammonium group of the γBB substrate. Enzyme binding and kinetic analyses on substrate analogues with P and As substituting for N in the trimethylammonium group show that the analogues are good BBOX substrates, which follow the efficiency trend N+>P+>As+. The results reveal that an uncharged carbon analogue of γBB is not a BBOX substrate, thus highlighting the importance of the energetically favorable cation-π interactions in productive substrate recognition. What's in the BBOX? Enzyme kinetics and substrate binding studies reveal that γ-butyrobetaine hydroxylase (BBOX)-catalyzed stereoselective hydroxylation of γ-butyrobetaine involves energetically favorable cation-π interactions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 112100-39-7